How to manage adverse effects of immunotherapy? The price of checkpoint inhibition
Crossref DOI link: https://doi.org/10.1007/s00761-024-01516-z
Published Online: 2024-04-09
Published Print: 2024-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Klein, Friederike
Text and Data Mining valid from 2024-04-09
Version of Record valid from 2024-04-09
Article History
Accepted: 18 March 2024
First Online: 9 April 2024
Interessenkonflikt
: F. Klein gibt an, dass kein Interessenkonflikt besteht.